A surgeon is asked by a pharmaceutical company to include their implant in all augmentation cases in exchange for travel sponsorship. This arrangement is best classified as:
-
A
A legitimate professional development opportunity
-
B
A conflict of interest that must be disclosed to patients
-
C
Standard industry practice requiring no disclosure
-
D
Permissible if the implant is FDA-approved